|
|
NOVADREN
-
| StockNo |
Product description |
| EB0280-418-10 |
NOVADREN
YELLOW AMPOULE 2ML/2% |
| EB0280-418-30 |
NOVADREN
BLUE AMPOULE 2ML/2% |
| EB0280-418-31 |
NOVADREN
GREEN AMPOULE 2ML/2% |
| INGREDIENT |
YELLOW |
BLUE |
GREEN |
| Procaine hydrochloride |
40 mg |
40 mg |
40 mg |
| Adrenaline |
80 mg |
80 mg |
- |
| L-noradrenaline |
- |
40 mg |
100 mg |
| Distilled water |
ad 2 ml |
ad 2 ml |
ad 2 ml |
ACTION:
A combined preparation with local anesthetic effect containing
procaine to which different concentrations of adrenaline and
noradrenaline have been added to prolong the effect. After
absorption, procaine exercises short-lived analgesic,
antiphlogistic, antishock, antiarrhythmic and spasmolytic
effects.
The adrenomimetic drugs adrenaline and noradrenaline reduce the
toxicity and prolong the anesthetic effect of procaine. Due to
their pronounced peripheral vasoconstrictive effect, the loss of
blood during surgical interventions decreases.
In stomatological practice - for obtaining a conduction
anesthesia during surgical interventions and painful
manipulations.
CONTRAINDICATIONS:
Hypersensitivity to procaine and adrenaline, myasthenia, sulfonamide
therapy, purulent processes at the place of application, arterial
hypotension.
The preparation should be applied with caution to patients with
pronounced cardiac, hepatic and renal insufficiency. |
SIDE EFFECTS:
General weakness, dizziness, noise in the ears, arterial
hypotension, skin eruptions, tachycardia, headache and tremor may be
observed after higher doses.
PRECAUTIONS:
Patients should be subjected to epicutaneous and other tests before
application of novadren for hypersensitivity.
DRUG INTERACTIONS:
The analgesic effect of Novadren decreases if used simultaneously
with glucose, analeptics and calcium preparations. Its
vasoconstructive effect can be reduced by phenothiazine derivatives.
Combined application with salicylates and sulfonamides may cause
inhibition of their anesthetic and bacterioststic effect.
DOSAGE AND ADMINISTRATION:
Usually 1-2 ampoules are enough to produce conduction anesthesia,
complete anesthesia being obtained after 5-10 min.
MEDICINAL FORM AND PACKAGE:
Ampoules of 2 ml/2 % in packs of 10, 20, and 100.
STORAGE:
At moderate temperature (15-30° C) in a place protected from light.
EXPIRY:
3 (three) years.
|
|
|
